NASDAQ:ACOR
Acorda Therapeutics Stock News
$0.661
+0 (+0%)
At Close: Apr 19, 2024
Will Acorda Therapeutics (ACOR) Report Negative Q2 Earnings? What You Should Know
04:07pm, Tuesday, 27'th Jul 2021
Acorda (ACOR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Acorda Therapeutics Continues To Maneuver For A Turnaround
01:21am, Saturday, 24'th Jul 2021
Acorda Therapeutics Continues To Maneuver For A Turnaround
ACOR Stock Increases Over 40% Pre-Market: Why It Happened
08:08am, Friday, 23'rd Jul 2021
The stock price of Acorda Therapeutics Inc (NASDAQ: ACOR) increased by over 40% pre-market. This is why it happened.
Acorda Therapeutics Shares Gains On Spain Distribution Pact For Parkinson's Med
07:17am, Friday, 23'rd Jul 2021
Acorda Therapeutics Inc (NASDAQ: ACOR) has entered into distribution and supply agreements with Esteve Pharmaceuticals S.A. to commercialize Inbrija 33 mg (levodopa inhalation powder, hard capsul
ACOR Stock Increased 24.67% After Hours: Why It Happened
01:31am, Friday, 23'rd Jul 2021
The stock price of Acorda Therapeutics Inc (NASDAQ: ACOR) increased 24.67% after hours. This is why it happened.
Acorda Therapeutics, Inc. (ACOR) CEO Ron Cohen on Q1 2021 Results - Earnings Call Transcript
04:44am, Sunday, 09'th May 2021
Acorda Therapeutics, Inc. (ACOR) CEO Ron Cohen on Q1 2021 Results - Earnings Call Transcript
Acorda Therapeutics (ACOR) Reports Q1 Loss, Tops Revenue Estimates
06:01pm, Thursday, 06'th May 2021
Acorda (ACOR) delivered earnings and revenue surprises of 3.15% and 30.30%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Acorda Therapeutics: Buying Before The Coast Is Clear
07:26pm, Thursday, 29'th Apr 2021
Acorda Therapeutics: Buying Before The Coast Is Clear
Acorda Therapeutics First Quarter 2021 Update: Webcast/Conference Call Scheduled for May 6, 2021
04:30pm, Thursday, 29'th Apr 2021
ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics First Quarter 2021 Update: Webcast/Conference Call Scheduled for May 6, 2021
Has Acorda Therapeutics (ACOR) Outpaced Other Medical Stocks This Year?
12:08pm, Wednesday, 10'th Mar 2021
Is (ACOR) Outperforming Other Medical Stocks This Year?
Acorda Therapeutics to Present at H.C. Wainwright Global Life Sciences Virtual Conference
05:44pm, Monday, 08'th Mar 2021
ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics to Present at H.C. Wainwright Global Life Sciences Virtual Conference
Acorda Therapeutics, Inc. (ACOR) CEO Ron Cohen on Q4 2020 Results - Earnings Call Transcript
09:20pm, Thursday, 04'th Mar 2021
Acorda Therapeutics, Inc. (ACOR) CEO Ron Cohen on Q4 2020 Results - Earnings Call Transcript
Acorda Therapeutics (ACOR) Reports Q4 Loss, Tops Revenue Estimates
06:58pm, Thursday, 04'th Mar 2021
Acorda (ACOR) delivered earnings and revenue surprises of -68.92% and 12.24%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Acorda Fourth Quarter/Year End 2020 Update: Webcast/Conference Call Scheduled for March 4, 2021
07:00am, Thursday, 25'th Feb 2021
ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Fourth Quarter/Year End 2020 Update: Webcast/Conference Call Scheduled for March 4, 2021
Acorda Therapeutics (ACOR) Sees Hammer Chart Pattern: Time to Buy?
06:50am, Wednesday, 24'th Feb 2021
Acorda Therapeutics (ACOR) has been struggling lately, but the selling pressure may be coming to an end soon.
